INOVIQ LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.56 AUD | -1.75% |
|
-2.61% | -15.79% |
| 12/06 | Inoviq's Neuro-Net Technology Opens Opportunities for Alzheimer’s Diagnostics, Treatment; Shares Surge 20% | MT |
| 07/06 | Inoviq Requests Trading Halt | MT |
Valuation
| Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 78.22 | 59.37 | - | - |
| Enterprise Value (EV) 1 | 78.22 | 52.27 | 50.47 | 52.77 |
| P/E ratio | -8.72 x | -5.71 x | -7.47 x | -17.5 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 66 x | 37.1 x | 7.24 x |
| EV / Revenue | - | 58.1 x | 31.5 x | 6.44 x |
| EV / EBITDA | - | -6.79 x | -7.11 x | -19.5 x |
| EV / FCF | - | -6.37 x | -6.91 x | -18.2 x |
| FCF Yield | - | -15.7% | -14.5% | -5.5% |
| Price to Book | - | 2.8 x | 2.8 x | 5.6 x |
| Nbr of stocks (in thousands) | 92,019 | 1,06,019 | - | - |
| Reference price 2 | 0.8500 | 0.5600 | 0.5600 | 0.5600 |
| Announcement Date | 29/08/23 | - | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 0.9 | 1.6 | 8.2 |
| EBITDA 1 | - | -7.7 | -7.1 | -2.7 |
| EBIT 1 | - | -9 | -8.4 | -3.9 |
| Operating Margin | - | -1,000% | -525% | -47.56% |
| Earnings before Tax (EBT) 1 | - | -9 | -8.4 | -3.9 |
| Net income 1 | -8.969 | -9 | -8.4 | -3.9 |
| Net margin | - | -1,000% | -525% | -47.56% |
| EPS 2 | -0.0975 | -0.0980 | -0.0750 | -0.0320 |
| Free Cash Flow 1 | - | -8.2 | -7.3 | -2.9 |
| FCF margin | - | -911.11% | -456.25% | -35.37% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 29/08/23 | - | - | - |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 7.1 | 8.9 | 6.6 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | -8.2 | -7.3 | -2.9 |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 0.2000 | 0.2000 | 0.1000 |
| Cash Flow per Share 2 | - | -0.0700 | -0.0600 | -0.0200 |
| Capex 1 | - | 0.5 | 0.2 | 0.2 |
| Capex / Sales | - | 55.56% | 12.5% | 2.44% |
| Announcement Date | 29/08/23 | - | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.79% | 39.61M | |
| +38.65% | 39.36B | |
| -8.62% | 38.52B | |
| +26.95% | 30.74B | |
| +10.74% | 25.92B | |
| -13.50% | 26.03B | |
| +44.87% | 14.13B | |
| +34.36% | 12.73B | |
| -7.14% | 11.29B | |
| -12.61% | 10.64B |
- Stock Market
- Equities
- IIQ Stock
- Financials INOVIQ Ltd
